Aminoguanidine prevents concanavalin A-induced hepatitis in mice

European Journal of Pharmacology

Volumn 396, Issue 2-3, 2000, Pages 125-130

  Okamoto, Toshihiro ^a   Masuda, Yoriko ^a   Kawasaki, Toru ^a   Shinohara, Motoki ^a   Matsuzaki, Katsuhiro ^a  

^a Nippon Chemiphar Co Ltd   (Japan)

Author keywords

Aminoguanidine; Concanavalin A; Hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOGUANIDINE; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 2; MESSENGER RNA; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; HEPATITIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LIVER NECROSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALANINE TRANSAMINASE; ANIMALS; CONCANAVALIN A; FEMALE; GUANIDINES; HEPATITIS, ANIMAL; INTERFERON TYPE II; LIVER; MICE; MICE, INBRED BALB C; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034685708     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00186-2     Document Type: Article

References (19)

1. Cottart C.H., Do L., Blanc M.C., Vaubourdolle M., Descamps G., Durand D., Galen F.X., Clot J.P. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology. 29:1999;809-813.
2. Curran R.D., Ferrari F.K., Kispert P.H., Stadler J., Stuehr D.J., Simmons R.L., Billiar T.R. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J. 5:1991;2085-2092.
3. Gantner F., Leist M., Lohse A.W., Germann P.G., Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice. The role of tumor necrosis factor. Hepatology. 21:1995;190-198.
4. Gardner C.R., Heck D.E., Yang C.S., Thomas P.E., Zhang X-J., DeGeorge G.L., Laskin J.D., Laskin D.L. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology. 26:1998;748-754.
5. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurol. Sci. 14:1991;60-67.
6. Gupta T.K., Toruner M., Chung M.K., Groszmann R.J. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology. 28:1998;926-931.
7. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S.I., Kimura T., Green S.J., Mak T.W., Taniguchi T., Vilcek J. Requirement for transcription factor IRF-1 in NO synthase inductioin in macrophages. Science. 263:1994;1612-1615.
8. Khatsenko O., Kikkawa Y. Nitric oxide differently affects constitutive cytochrome P450 isoforms in rat liver. J. Pharmacol. Exp. Ther. 280:1997;1463-1470.
9. Kwon N.S., Nathan C.F., Gilker C., Griffith O.W., Mattews D.E., Stuehr D.J. L-Citrulline production from L-arginine by macrophage NO synthase. J. Biol. Chem. 265:1990;13442-13445.
10. Mihm S., Fayyazi A., Ramadori G. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology. 26:1997;451-458.
11. Misko T.P., Moore W.M., Kasten T.P., Nickols G.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:1993;119-125.
12. Mizuhara H., Uno M., Seki N., Yamashita M., Yamaoka M., Ogawa T., Kaneda K., Fujii T., Senoh H., Fujiwara H. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisns of interleukin-6 for the manifestation of hepatitis. Hepatology. 23:1996;1608-1615.
13. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
14. Mulligan M.S., Hevel J.M., Marletta M.A., Ward P.A. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci. U. S. A. 88:1991;6338-6342.
15. Okamoto T., Furuya M., Yamakawa T., Yamamura K., Hino O. TNF-α gene expression in the liver of the IFN-γ transgenic mouse with chronic active hepatitis. Biochem. Biophys. Res. Commun. 226:1996;762-768.
16. Paul W.E., Seder R.A. Lymphocyte response and cytokines. Cell. 76:1994;241-251.
17. Samanta H., Engel D.A., Chao H.M., Thakur A., Garcia-Blanco M.A., Lengyel P. Interferons as gene activators. J. Biol. Chem. 261:1986;11849-11858.
18. Schmidt H.H.H.W., Walter U. NO at work. Cell. 78:1994;919-925.
19. Tiegs G., Hentshel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90:1992;196-203.